Midatech Pharma (NASDAQ: MTP) Reveals MTX110 Phase I DIPG Study Results
Hasnain Khan
October 19, 2020
Midatech Pharma Plc (NASDAQ: MTP) has announced today the promising headline results from Phase I study in patients with Diffuse Intrinsic Pontine Glioma (DIPG). The